The 2026 Healthtech Messaging Index
Oncora Medical
oncoramedical.com·scored November 1, 2026
7/38
Critical
Right now Oncora Medical's story is nearly invisible to both human buyers and AI. That's a foundation problem, and foundations can be rebuilt.
The AI Recommendation Check
When we asked AI who to recommend for Oncology-specific AI software for clinical documentation and cancer registry management, it named:
Buyer we put in the prompt: Cancer registrar, radiation oncologist, or clinical informatics leader at a hospital or cancer center. Both the buyer and the category were inferred from Oncora Medical’s homepage alone. The model had no web access.
Oncora Medical was not on the list.
A buyer who asked AI this question got 8 names and moved on. Oncora Medical never came up.
We asked AI who it recommends for "Cancer registrar, radiation oncologist, or clinical informatics leader at a hospital or cancer center" looking for "Oncology-specific AI software for clinical documentation and cancer registry management". It named Tempus AI, Flatiron Health, Elekta, Varian Medical Systems, Veracyte. You did not appear. AI can't recommend what it can't clearly understand.
Overall assessment
The single biggest strength is the clear oncology vertical focus, which at least tells visitors the domain; 'Registry AI' and 'Clinical AI' create minimal product differentiation. The single biggest gap is everything else ... there is no buyer problem, no proof, no social proof, no promised outcome, and no CTA architecture, making this homepage nearly invisible to both human buyers and AI recommendation engines.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
02Rebellion / Movement
“No named enemy, status quo, or industry pattern the company is pushing against anywhere on the page.”
There is zero rebellion language ... no named frustration with legacy workflows, broken registries, or incumbent tools ... making this purely mercenary in tone.
All 19 signals, scored 0 to 2.
Total 7/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“Oncology AI Solutions" / "Clinical Expertise, Technical Excellence”
The tagline gestures at oncology AI but gives no clear problem, no point of view, and no obvious audience ... a stranger can't answer all three questions in 7 seconds.
- 0
02Rebellion / Movementweakest
“No named enemy, status quo, or industry pattern the company is pushing against anywhere on the page.”
There is zero rebellion language ... no named frustration with legacy workflows, broken registries, or incumbent tools ... making this purely mercenary in tone.
- 1
03Owned Language & Category
“Registry AI" and "Clinical AI”
The product names hint at a frame but are generic compound labels, not coined terms or owned categories that an AI would quote as distinctively Oncora's.
- 1
04ICP Clarity
“Bringing oncology-specific artificial intelligence to healthcare”
'Healthcare' is too broad ... no role (e.g., cancer registrar, radiation oncologist), no facility size, no stage is specified, so a visitor cannot instantly confirm they are the target buyer.
- 0
05Problem Leadership
“No buyer problem stated anywhere; page leads with "Clinical Expertise, Technical Excellence.”
The page opens with a company-centric capability claim, not a buyer pain point ... the buyer's problem is never named.
- 1
06Solution Clarity
“AI scribe with oncology-specific documentation" / "Transform your cancer registry into a strategic asset”
Each product gets a one-liner, but the overall company's offering cannot be summarized in a single sentence from the hero alone without drilling into the product tiles.
- 0
07Cost of Inaction
“No cost of inaction, stakes, or downside of the status quo mentioned anywhere on the page.”
There is no language describing what happens if the buyer does nothing ... no lost time, missed data, revenue risk, or compliance consequence.
- 0
08Promised Land
“No 'after' state described beyond "strategic asset" ... no specific promised outcome for the buyer.”
The page never paints a concrete picture of life after adopting the product; 'strategic asset' is a vague aspiration, not a promised land.
Trust Signal
4 signals
- 0
09Proof & Evidence
“No numbers, percentages, before/after deltas, or named outcomes anywhere on the page.”
The entire page contains zero quantitative proof ... no time saved, cases processed, accuracy rates, or customer results.
- 0
10Social Proof
“No customer logos, testimonials, named case studies, or any third-party social proof on the page.”
There is no social proof of any kind ... not a single customer name, quote, or logo appears.
- 0
11Authority & Credibility
“No founder credentials, research, awards, frameworks, or any demonstrated authority on the page.”
Authority is claimed implicitly via 'Clinical Expertise' but nothing is demonstrated ... no bios, publications, or credentials are present.
- 0
12Alternatives Acknowledged
“No mention of alternatives, competitors, or the 'do nothing' option anywhere on the page.”
The page never acknowledges what buyers might do instead, making it impossible to position against the real decision set.
AI Signal
6 signals
- 0
13Customer Focus
“Clinical Expertise, Technical Excellence" ... page leads with company attributes throughout.”
The page is entirely about the company's capabilities and conference presence; the customer never appears as a protagonist with a transformation arc.
- 1
14AI-Parmesan Index
“oncology-specific artificial intelligence" / "AI scribe with oncology-specific documentation”
AI is mentioned with light domain specificity ('oncology-specific') but no mechanistic explanation of how it works, making it better than generic AI-sprinkle but still not substantive.
- 0
15LLM Quotability
“No clean, declarative, citation-ready sentences exist ... only vague taglines like "Clinical Expertise, Technical Excellence.”
There are no quotable factual claims an LLM could lift to recommend this company with confidence over a competitor.
- 1
16Copyright Freshness
“ARS 108th Annual Meeting / April 30 - May 3, 2026”
A future conference date signals the page is current, but there are no dated blog posts, case studies, or a visible copyright year to anchor recency signals.
- 1
17Entity Distinctiveness
“Registry AI" and "Clinical AI" in oncology context”
The oncology focus provides some distinctiveness, but the page's generic structure and lack of owned language mean competitors could swap logos and the content would still apply.
- 0
18AI Recommendation Check
“AI's picks: Tempus AI, Flatiron Health, Elekta, Varian Medical Systems, Veracyte, Definitive Healthcare. You were not named.”
We asked AI who it recommends for "Cancer registrar, radiation oncologist, or clinical informatics leader at a hospital or cancer center" looking for "Oncology-specific AI software for clinical documentation and cancer registry management". It named Tempus AI, Flatiron Health, Elekta, Varian Medical Systems, Veracyte. You did not appear. AI can't recommend what it can't clearly understand.
Conversion Signal
1 signal
- 0
19Path & CTA Clarity
“Schedule a Meeting" is the only CTA; no numbered process, no soft secondary CTA, no visible path.”
There is one weak CTA (conference meeting scheduler) with no primary/secondary CTA pairing and no process steps ... conversion architecture is essentially absent.
Your move
Think Oncora Medical’s score is wrong? Good. Let’s look at it together.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Oncora Medical the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.